Abstract:Muscular Dystrophy is a group of genetic disorders that progressively affect the strength and functioning of muscles, thereby affecting millions of people worldwide. The lifetime nature of MD requires continuous follow-up care due to its progressive nature. This conceptual paper proposes an Internet of Things-based system to support the management of MD through remote, multi-dimensional monitoring of patients in order to provide real-time health status updates. Traditional methods have failed to give actionable data in real time, hence denying healthcare providers the opportunity to make evidence-based decisions. Technology-driven approaches are urgently needed to provide deep insights into disease progression and patient health. It aims to enhance treatment strategies, enabling patients to better manage their condition and giving healthcare professionals more confidence in their management decisions.
What problem does this paper attempt to address?
The problem that this paper attempts to solve is: to improve the management of Muscular Dystrophy (MD) by developing a real - time personalized health monitoring system based on the Internet of Things (IoT). Specifically, the research aims to:
1. **Provide real - time health status updates**: Traditional monitoring methods cannot provide real - time and actionable data, making it difficult for healthcare providers to make evidence - based decisions. Therefore, this study proposes a system that can monitor patients' health conditions in real - time and provide updates.
2. **Support multi - dimensional monitoring**: The system will integrate multiple sensors to monitor muscle activity, heart function, and environmental factors (such as temperature and humidity) to provide comprehensive health data.
3. **Enhance treatment strategies**: By using advanced algorithms to analyze the collected data, the system can predict disease progression and assess patients' health conditions, thereby helping to optimize treatment plans, enabling patients to better manage their conditions, and enhancing the confidence of medical professionals in their management decisions.
4. **Overcome the limitations of existing technologies**: Current wearable devices cannot monitor specific biomarkers (such as creatine kinase (CK) and transaminases (ALT/AST)), which are very important for evaluating muscle and metabolic stress. To this end, the system introduces point - of - care testing (POCT) technology, which can efficiently evaluate these markers in small blood samples.
5. **Achieve personalized care**: The system not only provides real - time health monitoring, but also provides personalized diet, exercise, and medication suggestions for patients through mobile applications, enabling patients to make informed health decisions.
### Overview of the system architecture
The architecture of the system includes the following key parts:
- **Sensor layer**: It includes EMG sensors, CPK monitoring, ALT/AST monitoring, cardiopulmonary sensors, environmental sensors, etc., which are used to collect various health parameters.
- **Gateway layer**: It is responsible for collecting data from various sensors, pre - processing (such as filtering, FFT transformation, etc.), and then uploading the processed data to the cloud.
- **Cloud platform layer**: It uses machine learning models (such as random forest, SVM, ARIMA, LSTM, etc.) to conduct in - depth analysis of data and provide real - time insights and risk prediction.
- **Feedback mechanism**: By continuously accumulating new data and observing actual results, the system can continuously optimize its algorithms, improve prediction accuracy, and make personalized adjustments according to the specific needs of patients.
### Risk scoring formula
In order to assess the overall risk of patients, the system introduces a risk scoring formula, where:
\[
\text{RiskScore} = 0.5\times\frac{\text{CPK}}{1000}+ 0.25\times\frac{\text{ALT}}{100}+ 0.25\times\frac{\text{AST}}{100}+ 0.1\times\text{EMG Amplitude (mV)}
\]
where:
- CPK (creatine kinase) is a very sensitive indicator of muscle damage, with a weight of 0.5.
- ALT (alanine aminotransferase) and AST (aspartate aminotransferase) will also increase in case of muscle damage, with a weight of 0.25 each.
- EMG amplitude (electromyogram amplitude) reflects muscle strength, with a weight of 0.1.
This risk scoring system can identify potential health problems at an early stage and issue timely alarms so that medical providers can take intervention measures.
In conclusion, this paper aims to improve the management and care of patients with Muscular Dystrophy by constructing a real - time personalized health monitoring system based on the Internet of Things, providing more accurate and timely health monitoring and intervention means.